indoline has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Candeias, NR; Kandhavelu, M; Le, HTT; Murugesan, A; Ramesh, T; Yli-Harja, O | 1 |
| Dhayabaran, VV; Kumar, MR; Manikandan, A; Sivakumar, A | 1 |
| Bian, J; Ge, R; Li, Z; Xie, Z; Xu, X; Zhang, Z; Zuo, M | 1 |
3 other study(ies) available for indoline and Cancer of Prostate
| Article | Year |
|---|---|
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer.
Topics: Abiraterone Acetate; Androgen Receptor Antagonists; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Male; Prostatic Neoplasms; Purinergic P2Y Receptor Agonists; Receptors, Androgen; Receptors, Purinergic P2Y1 | 2022 |
An eco-friendly catalytic system for multicomponent, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanism.
Topics: Alkaline Phosphatase; Antineoplastic Agents; Catalysis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Male; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; Spiro Compounds; Structure-Activity Relationship | 2018 |
Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Humans; Indoles; Male; Molecular Docking Simulation; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Receptors, Androgen; Thiohydantoins | 2017 |